• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

FRMs now account managers?





















I’d be looking for another job if I was an FRM. It’s a temporary position, and nobody in their right business mind has any interest in taking financial responsibility for this mess. Another Novartis failure on full display.
 




I’d be looking for another job if I was an FRM. It’s a temporary position, and nobody in their right business mind has any interest in taking financial responsibility for this mess. Another Novartis failure on full display.

Spot on. Cardiologists are not willing to take the risk, especially when Novartis is the partner. If offices don’t buy, the frm position is not needed.
 




















the reimbursement team regional directors are so very wise and have this all under control. frms need not worry.

If you think you are anywhere near where the finger should be pointing you are sadly showing your lack of knowledge in how companies are run. Try pointing your blame a bit higher than regional directors
 








FRMs, MSLs are designed non-promotional roles.

FRMs focus on helping patients gain access AFTER a HCP decides to prescribe.

Although part of a multifunctional team, FRMs should not be directed by sales/sales leadership or appear to be an extension of the sales role.

Salespeople sell & are incentivized for it, usually with small IC plan.

FRMs, usually are given bonus (if any) aligned with how the company performs overall.

DOJ, OIG, FTC, FDA (federal government mainly) want people with good judgment snd integrity in these roles to avoid appearance of kickbacks, among other concerns.

Novartis never learns.
 












I have to say being on the MS side i wish some of the FRM’s would try to sell and actually be helpful and communicate updates consistently. That’s the issue we have is more a culture issue. FRM’s see when a provider puts a patient on therapy—how much time does it take to send an email/txt, etc to your rep and be excited. It’s like we are operating in silos and it’s disappointing. Upper management needs to look at pull-through rates and start holding them accountability just like we are for growing our business